Provided by Tiger Trade Technology Pte. Ltd.

NeuroPace Inc.

13.00
-0.1300-0.99%
Post-market: 13.000.00000.00%18:04 EDT
Volume:302.26K
Turnover:3.93M
Market Cap:437.67M
PE:-19.82
High:13.23
Open:13.02
Low:12.68
Close:13.13
52wk High:18.98
52wk Low:7.56
Shares:33.67M
Float Shares:22.91M
Volume Ratio:1.46
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6560
EPS(LYR):-0.6560
ROE:-158.74%
ROA:-10.20%
PB:23.00
PE(LYR):-19.82

Loading ...

Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE)

TIPRANKS
·
Mar 18

NeuroPace assumed with an Overweight at Wells Fargo

TIPRANKS
·
Mar 18

NeuroPace to Present at Leerink 2026 Global Healthcare Conference

Reuters
·
Mar 06

Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access

TIPRANKS
·
Mar 05

NeuroPace (NPCE) Loss Narrowing In Q4 Tests Bullish Profitability Narrative

Simply Wall St.
·
Mar 05

Neuropace Chief Medical Officer Martha Morrell Disposes of Common Shares

Reuters
·
Mar 05

NeuroPace forecasts 2026 revenue of $98 million to $100 million

Reuters
·
Mar 04

NeuroPace sees Q1 revenue $21M-$22M, consensus $21.93M

TIPRANKS
·
Mar 04

NeuroPace Q4 EPS $(0.08) Beats $(0.17) Estimate, Sales $26.588M Beat $24.791M Estimate

Benzinga
·
Mar 04

BRIEF-NeuroPace, Inc. Q4 EPS USD -0.08

Reuters
·
Mar 04

Neuropace, Inc. Q4 EPS USD -0.08

THOMSON REUTERS
·
Mar 04

Neuropace Inc - Q1 2026 Revenue Guidance $21 Mln-$22 Mln

THOMSON REUTERS
·
Mar 04

Press Release: NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook

Dow Jones
·
Mar 04

NeuroPace (NPCE) Receives a Buy from Lake Street

TIPRANKS
·
Mar 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02

Neuropace Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
Feb 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

NeuroPace Inc. Schedules Fourth-Quarter Financial Results Webcast and Conference Call

Reuters
·
Feb 21

NeuroPace Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 27

NeuroPace sees FY26 revenue $98M-$100M, consensus $98.44M

TIPRANKS
·
Jan 13